News
NASA: No evidence Elon Musk’s SpaceX is not complying with drug and alcohol-free regulations
The National Aeronautics and Space Administration (NASA) has issued a comment about The Wall Street Journal‘s claims that CEO Elon Musk uses drugs such as ketamine, LSD, cocaine, ecstasy, and psychedelic mushrooms. Citing sources reportedly familiar with Musk and his companies, the WSJ claimed in its report that the CEO’s drug use has made Tesla and SpaceX executives worried. The publication also highlighted that the use of illicit substances could result in Musk losing his security clearance.
As noted by the WSJ, Musk’s attorney, Alex Spiro, stated that there were false facts in the publication’s story about the Tesla and SpaceX CEO. Musk, for his part, also posted his criticisms of the report. The CEO talked in particular about the time he took a puff of marijuana during an appearance on the Joe Rogan Experience podcast. Musk noted that he underwent random drug testing for three years following the event at NASA’s request, but “not even trace quantities were found of any drugs or alcohol.”
As stated in a report from Bloomberg News, NASA noted that it expects its commercial partners to meet all workplace safety requirements. “The agency does not have evidence of non-compliance from SpaceX on how the company addresses the drug- and alcohol-free workforce regulations. We expect our commercial partners to meet all workplace safety requirements in the execution of those missions and the services they provide the American people,” NASA noted.
It would not be an exaggeration to state that SpaceX is carrying the United States’ space program on its back today. Its Falcon 9 workhorse continues to not only launch payloads into orbit, but also bring astronauts to and from the International Space Station (ISS). Musk aims to use SpaceX to make life multiplanetary, and maintaining the company’s NASA contracts is a crucial part of that goal.
The @WSJ has become so desperate for circulation that they lie on a regular basis— Elon Musk (@elonmusk) January 9, 2024
The Wall Street Journal‘s report has attracted a lot of attention, though some of the publication’s claims seem to have been addressed by SpaceX itself. The report, for one, claimed that “SpaceX executives privately talked about their worries Musk was on drugs” following a company meeting in 2017, where Musk was reportedly incomprehensible at times. Citing one of its sources, the WSJ claimed that the event was described as “nonsensical,” “unhinged,” and “cringeworthy.”
SpaceX did not directly address the WSJ‘s claims, but the private space company did post the entirety of the 2017 meeting in question, which was held around the same time as Tesla’s “production hell” with the Model 3 sedan. As could be seen in the video, Musk admitted to SpaceX employees that he did not really have much sleep before the event. The CEO also stuttered a lot during the meeting, though anyone who’s followed Musk over the years would know that his speech at the 2017 meeting is typical of Musk.
A spokesperson from The Wall Street Journal has maintained that the publication stands by its claims in its report. “We stand by our reporting,” the spokesperson said.
Don’t hesitate to contact us with news tips. Just send a message to simon@teslarati.com to give us a heads up.
Elon Musk
SpaceX issues statement on Starship V3 Booster 18 anomaly
The incident unfolded during gas-system pressure testing at the company’s Massey facility in Starbase, Texas.
SpaceX has issued an initial statement about Starship Booster 18’s anomaly early Friday. The incident unfolded during gas-system pressure testing at the company’s Massey facility in Starbase, Texas.
SpaceX’s initial comment
As per SpaceX in a post on its official account on social media platform X, Booster 18 was undergoing gas system pressure tests when the anomaly happened. Despite the nature of the incident, the company emphasized that no propellant was loaded, no engines were installed, and personnel were kept at a safe distance from the booster, resulting in zero injuries.
“Booster 18 suffered an anomaly during gas system pressure testing that we were conducting in advance of structural proof testing. No propellant was on the vehicle, and engines were not yet installed. The teams need time to investigate before we are confident of the cause. No one was injured as we maintain a safe distance for personnel during this type of testing. The site remains clear and we are working plans to safely reenter the site,” SpaceX wrote in its post on X.
Incident and aftermath
Livestream footage from LabPadre showed Booster 18’s lower half crumpling around the liquid oxygen tank area at approximately 4:04 a.m. CT. Subsequent images posted by on-site observers revealed extensive deformation across the booster’s lower structure. Needless to say, spaceflight observers have noted that Booster 18 would likely be a complete loss due to its anomaly.
Booster 18 had rolled out only a day earlier and was one of the first vehicles in the Starship V3 program. The V3 series incorporates structural reinforcements and reliability upgrades intended to prepare Starship for rapid-reuse testing and eventual tower-catch operations. Elon Musk has been optimistic about Starship V3, previously noting on X that the spacecraft might be able to complete initial missions to Mars.
Investor's Corner
Tesla analyst maintains $500 PT, says FSD drives better than humans now
The team also met with Tesla leaders for more than an hour to discuss autonomy, chip development, and upcoming deployment plans.
Tesla (NASDAQ:TSLA) received fresh support from Piper Sandler this week after analysts toured the Fremont Factory and tested the company’s latest Full Self-Driving software. The firm reaffirmed its $500 price target, stating that FSD V14 delivered a notably smooth robotaxi demonstration and may already perform at levels comparable to, if not better than, average human drivers.
The team also met with Tesla leaders for more than an hour to discuss autonomy, chip development, and upcoming deployment plans.
Analysts highlight autonomy progress
During more than 75 minutes of focused discussions, analysts reportedly focused on FSD v14’s updates. Piper Sandler’s team pointed to meaningful strides in perception, object handling, and overall ride smoothness during the robotaxi demo.
The visit also included discussions on updates to Tesla’s in-house chip initiatives, its Optimus program, and the growth of the company’s battery storage business. Analysts noted that Tesla continues refining cost structures and capital expenditure expectations, which are key elements in future margin recovery, as noted in a Yahoo Finance report.
Analyst Alexander Potter noted that “we think FSD is a truly impressive product that is (probably) already better at driving than the average American.” This conclusion was strengthened by what he described as a “flawless robotaxi ride to the hotel.”
Street targets diverge on TSLA
While Piper Sandler stands by its $500 target, it is not the highest estimate on the Street. Wedbush, for one, has a $600 per share price target for TSLA stock.
Other institutions have also weighed in on TSLA stock as of late. HSBC reiterated a Reduce rating with a $131 target, citing a gap between earnings fundamentals and the company’s market value. By contrast, TD Cowen maintained a Buy rating and a $509 target, pointing to strong autonomous driving demonstrations in Austin and the pace of software-driven improvements.
Stifel analysts also lifted their price target for Tesla to $508 per share over the company’s ongoing robotaxi and FSD programs.
Elon Musk
SpaceX Starship Version 3 booster crumples in early testing
Photos of the incident’s aftermath suggest that Booster 18 will likely be retired.
SpaceX’s new Starship first-stage booster, Booster 18, suffered major damage early Friday during its first round of testing in Starbase, Texas, just one day after rolling out of the factory.
Based on videos of the incident, the lower section of the rocket booster appeared to crumple during a pressurization test. Photos of the incident’s aftermath suggest that Booster 18 will likely be retired.
Booster test failure
SpaceX began structural and propellant-system verification tests on Booster 18 Thursday night at the Massey’s Test Site, only a few miles from Starbase’s production facilities, as noted in an Ars Technica report. At 4:04 a.m. CT on Friday, a livestream from LabPadre Space captured the booster’s lower half experiencing a sudden destructive event around its liquid oxygen tank section. Post-incident images, shared on X by @StarshipGazer, showed notable deformation in the booster’s lower structure.
Neither SpaceX nor Elon Musk had commented as of Friday morning, but the vehicle’s condition suggests it is likely a complete loss. This is quite unfortunate, as Booster 18 is already part of the Starship V3 program, which includes design fixes and upgrades intended to improve reliability. While SpaceX maintains a rather rapid Starship production line in Starbase, Booster 18 was generally expected to validate the improvements implemented in the V3 program.
Tight deadlines
SpaceX needs Starship boosters and upper stages to begin demonstrating rapid reuse, tower catches, and early operational Starlink missions over the next two years. More critically, NASA’s Artemis program depends on an on-orbit refueling test in the second half of 2026, a requirement for the vehicle’s expected crewed lunar landing around 2028.
While SpaceX is known for diagnosing failures quickly and returning to testing at unmatched speed, losing the newest-generation booster at the very start of its campaign highlights the immense challenge involved in scaling Starship into a reliable, high-cadence launch system. SpaceX, however, is known for getting things done quickly, so it would not be a surprise if the company manages to figure out what happened to Booster 18 in the near future.
SpaceX issues statement on Starship V3 Booster 18 anomaly
Tesla analyst maintains $500 PT, says FSD drives better than humans now
